Baron and Budd Warns Women About Side Effects of YAZ, Yasmin
FDA Requires New Warnings for YAZ, Yasmin Regarding Blood Clots
DALLAS--(BUSINESS WIRE)--May 16, 2012 - The Federal Drug Administration (FDA) has recently decided to strengthen warning labels on the oral contraceptive YAZ and its sister drug Yasmin regarding increased risks of blood clots from using the medications. Baron and Budd, a national law firm dedicated to protecting the rights of consumers, is warning women about the new labels and the adverse health effects of YAZ, Yasmin, Beyaz and Ocella.
YAZ, Yasmin, Beyaz and Ocella belong to a newer family of birth control pills that contain drospirenone (DRSP). Studies have found that women who use birth control pills that contain DRSP are at an increased risk of developing blood clots when compared to traditional birth control pills.
The new FDA warnings follow the recommendations of an FDA advisory committee that evaluated the potential health risks of YAZ and other DRSP-containing birth control pills. After reviewing studies of the health risks, the committee recommended stronger warning labels for the DRSP family of drugs.
“Women need to be aware of things that could threaten their health,” said Laura Baughman, attorney at Baron and Budd. “Even though YAZ has been aggressively marketed to treat a variety of issues, that does not mean that it can deliver on all of those promises. In fact, in 2008 Bayer was forced to run a $20 million ad campaign to clarify the company's previous commercials about YAZ, which, according to the FDA, were misleading because the ads promoted YAZ for conditions that it was not approved for and downplayed potential risks of the drugs – like blood clots.”
The most common health issues associated with YAZ are blood clots and other problems associated with blood clots such as heart attack, stroke and pulmonary embolism.
More than 10,000 lawsuits have been filed by women who have suffered blood clots and other adverse side effects from taking YAZ or Yasmin, including at least four class action lawsuits. Bayer recently agreed to settle the first group of lawsuits regarding blood clots for approximately $110 million. Other lawsuits are still in process. Regardless, it is not too late to file a lawsuit for serious health effects from YAZ, Yasmin, Beyaz or Ocella.
Learn more about YAZ and connect with others on our Facebook group: http://www.facebook.com/Yaz.Help.
If you or someone you know has suffered a serious effect while taking YAZ, Yasmin, Beyaz or Ocella, call Baron and Budd at 1.888.349.5511 or email us at firstname.lastname@example.org.
Baron and Budd has a 30 year history of protecting the rights of consumers. The firm prides itself on remaining at the forefront of meaningful litigation that positively impacts the lives of consumers. Baron and Budd was one of the law firms that pursued justice for people with serious health conditions caused by the diet drug Fen-Phen and helped oversee a settlement in litigation regarding the drug. The firm currently represents thousands of patients who have suffered serious health issues from the diabetes drug Avandia.
About Baron & Budd, P.C.
The law firm of Baron & Budd, P.C., with offices in Dallas, Baton Rouge, Austin and Los Angeles, is a nationally recognized law firm with a 30-year history of “Protecting What's Right” for people, communities and businesses harmed by negligence. Baron & Budd's size and resources enable the firm to take on large and complex cases. The firm represents individuals, governmental and business entities in areas as diverse as water contamination, Gulf oil spill, Qui Tam, California Proposition 65 violations, dangerous medications and medical devices, Chinese drywall, insurance claims, commercial litigation, consumer fraud, securities fraud and asbestos-related illnesses such as mesothelioma. Learn more about the mesothelioma attorneys at Baron & Budd.
Contact: Baron & Budd, P.C.
Amanda Theaker, 214-991-1051
Posted: May 2012